SmartPharm Therapeutics, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From SmartPharm Therapeutics, Inc.
Editas regains rights to ocular programs first partnered with Allergan in 2017. Newly public F-star will focus on bispecific antibodies for cancer, TriSalus acquires oncology candidate from Dynavax.
- Gene Therapy, Cell Therapy
- Other Names / Subsidiaries
- Sorrento Therapeutics, Inc.